Concepedia

James Fossetta

JF

23

Publications

1.2K

Citations

17

H-Index

1988

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Bloomfield College

United States Pharmacopeial Convention

Inflammation Research Foundation

James Fossetta is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1988–2016

23

Publications

23

Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation.

Thierry Fischmann, Alan Hruza, Xiao Da Niu et al. · Nature Structural Biology · 1999 · 452 citations

, , +9

Pharmacological Characterization of Sch527123, a Potent Allosteric CXCR1/CXCR2 Antagonist

Waldemar Gonsiorek, Xuedong Fan, David Hesk et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 127 citations

Discovery of 2-Hydroxy-<i>N</i>,<i>N</i>-dimethyl-3-{2-[[(<i>R</i>)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123):  A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor Antagonist

Michael P. Dwyer, Younong Yu, Jianping Chao et al. · Journal of Medicinal Chemistry · 2006 · 113 citations · Full text

, , +18

The carboxyl-terminal region of human interferon γ is important for biological activity: mutagenic and NMR analysis

Daniel Lundell, Charles A. Lunn, David C. Dalgarno et al. · Protein Engineering Design and Selection · 1991 · 67 citations

Pharmacological Analysis of Calcium Responses Mediated by the Human A3 Adenosine Receptor in Monocyte-Derived Dendritic Cells and Recombinant Cells

James Fossetta, James Jackson, Gregory Deno et al. · Molecular Pharmacology · 2003 · 63 citations

Rows per page

1–5 of 23